Sugwin-VG 1mg/500mg/0.2mg Tablet
Marketer
MaxQure Labs
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Sugwin-VG 1mg/500mg/0.2mg Tablet
Diabetia-Comb 1mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabetia-Comb should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan incorporating a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and be prepared to treat them with a fast-acting glucose source (e.g., sugary foods, fruit juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Primary Ingredients of Sugwin-VG 1mg/500mg/0.2mg Tablet
No text provided to rephrase.
Uses of Sugwin-VG 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Sugwin-VG 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or breaking it. Administer Sugwin-VG 1mg/500mg/0.2mg Tablet on an empty stomach.
Common Side effects of Sugwin-VG 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Sugwin-VG 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sugwin-VG 1mg/500mg/0.2mg Tablet on an empty stomach.
How Sugwin-VG 1mg/500mg/0.2mg Tablet works:
Each Sugwin-VG tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sugwin-VG 1mg/500mg/0.2mg Tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Sugwin-VG 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before taking this medicine.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Sugwin-VG 1mg/500mg/0.2mg tablets is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyUNSAFE
The use of Sugwin-VG 1mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be prevented. Medical advice is necessary. Furthermore, its use is contraindicated in patients with severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Sugwin-VG 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Individuals with mild to moderate hepatic dysfunction should commence treatment with a reduced Sugwin-VG 1mg/500mg/0.2mg tablet dosage; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Sugwin-VG 1mg/500mg/0.2mg Tablet :
Should you forget a Sugwin-VG 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sugwin-VG 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently